Commerce Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$244K Sell
1,292
-133
-9% -$23.2K ﹤0.01% 1207
2025
Q4
$242K Buy
+1,425
New +$218K ﹤0.01% 1152
2025
Q2
Sell
-2,097
Closed -$260K 1200
2025
Q1
$260K Buy
2,097
+21
+1% +$2.74K ﹤0.01% 1057
2024
Q4
$256K Buy
+2,076
New +$245K ﹤0.01% 1074
2024
Q3
Sell
-6,010
Closed -$641K 1226
2024
Q2
$641K Sell
6,010
-54,022
-90% -$5.94M ﹤0.01% 764
2024
Q1
$7.23M Buy
60,032
+4,894
+9% +$599K 0.05% 259
2023
Q4
$6.78M Buy
+55,138
New +$6.88M 0.05% 261
2023
Q2
Sell
-1,411
Closed -$206K 1181
2023
Q1
$206K Buy
+1,411
New +$209K ﹤0.01% 1090
2022
Q3
Sell
-1,466
Closed -$229K 1154
2022
Q2
$229K Sell
1,466
-651
-31% -$100K ﹤0.01% 1050
2022
Q1
$330K Buy
2,117
+1
+0% +$145 ﹤0.01% 964
2021
Q4
$269K Sell
2,116
-97
-4% -$12.7K ﹤0.01% 1051
2021
Q3
$288K Buy
2,213
+169
+8% +$25.5K ﹤0.01% 1014
2021
Q2
$363K Buy
2,044
+52
+3% +$9.01K ﹤0.01% 939
2021
Q1
$327K Sell
1,992
-484
-20% -$79.6K ﹤0.01% 940
2020
Q4
$408K Buy
2,476
+49
+2% +$7.3K ﹤0.01% 849
2020
Q3
$346K Buy
+2,427
New +$301K ﹤0.01% 812
2020
Q2
Sell
-2,861
Closed -$285K 1024
2020
Q1
$285K Buy
2,861
+306
+12% +$39.6K ﹤0.01% 779
2019
Q4
$381K Buy
2,555
+474
+23% +$64.5K ﹤0.01% 737
2019
Q3
$267K Buy
2,081
+384
+23% +$51.5K ﹤0.01% 819
2019
Q2
$242K Buy
+1,697
New +$228K ﹤0.01% 827

Other funds holding JAZZ

Commerce Bank's JAZZ Position: Q1 2026 in Review

Commerce Bank reduced its Jazz Pharmaceuticals (JAZZ) stake by 9.3% in Q1 2026, selling an estimated $23.2K and leaving 1,292 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #1207.

Commerce Bank first reported a position in JAZZ in Q2 2019 and has held it in 20 quarters since. The position peaked at $7.23M in Q1 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Commerce Bank held 1,292 shares of Jazz Pharmaceuticals worth $244K as of Q1 2026.
  • Commerce Bank sold 133 Jazz Pharmaceuticals shares in Q1 2026, an estimated $23.2K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Commerce Bank's portfolio in Q1 2026, its #1207 holding.
  • Commerce Bank first reported a position in Jazz Pharmaceuticals in Q2 2019 and has held it in 20 quarters since.
  • Commerce Bank's Jazz Pharmaceuticals position peaked at $7.23M in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.